[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Incretin-Based Drugs Market Report 2017

October 2017 | 103 pages | ID: UBB2B436130PEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Incretin-Based Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Incretin-Based Drugs in these regions, from 2012 to 2022 (forecast).
United States Incretin-Based Drugs market competition by top manufacturers/players, with Incretin-Based Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • AstraZeneca plc
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Takeda Pharmaceutical Company Ltd
  • Sanofi S.A.
  • Novartis AG
  • Eli Lilly and Company
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • By Formulation
    • Injectable
    • Oral
  • By Drug
    • Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
    • Glucagon-Like Peptide-1 Receptor (GLP-1) Agonists
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Incretin-Based Drugs for each application, including
  • Hospitals
  • Pharmacies
  • Diagnostic Centers
  • Other
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Incretin-Based Drugs Market Report 2017

1 INCRETIN-BASED DRUGS OVERVIEW

1.1 Product Overview and Scope of Incretin-Based Drugs
1.2 Classification of Incretin-Based Drugs by Product Category
  1.2.1 United States Incretin-Based Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Incretin-Based Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Injectable
  1.2.4 Oral
1.3 United States Incretin-Based Drugs Market by Application/End Users
  1.3.1 United States Incretin-Based Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospitals
  1.3.3 Pharmacies
  1.3.4 Diagnostic Centers
  1.3.5 Other
1.4 United States Incretin-Based Drugs Market by Region
  1.4.1 United States Incretin-Based Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Incretin-Based Drugs Status and Prospect (2012-2022)
  1.4.3 Southwest Incretin-Based Drugs Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Incretin-Based Drugs Status and Prospect (2012-2022)
  1.4.5 New England Incretin-Based Drugs Status and Prospect (2012-2022)
  1.4.6 The South Incretin-Based Drugs Status and Prospect (2012-2022)
  1.4.7 The Midwest Incretin-Based Drugs Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Incretin-Based Drugs (2012-2022)
  1.5.1 United States Incretin-Based Drugs Sales and Growth Rate (2012-2022)
  1.5.2 United States Incretin-Based Drugs Revenue and Growth Rate (2012-2022)

2 UNITED STATES INCRETIN-BASED DRUGS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Incretin-Based Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Incretin-Based Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Incretin-Based Drugs Average Price by Players/Suppliers (2012-2017)
2.4 United States Incretin-Based Drugs Market Competitive Situation and Trends
  2.4.1 United States Incretin-Based Drugs Market Concentration Rate
  2.4.2 United States Incretin-Based Drugs Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Incretin-Based Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES INCRETIN-BASED DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Incretin-Based Drugs Sales and Market Share by Region (2012-2017)
3.2 United States Incretin-Based Drugs Revenue and Market Share by Region (2012-2017)
3.3 United States Incretin-Based Drugs Price by Region (2012-2017)

4 UNITED STATES INCRETIN-BASED DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Incretin-Based Drugs Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Incretin-Based Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Incretin-Based Drugs Price by Type (2012-2017)
4.4 United States Incretin-Based Drugs Sales Growth Rate by Type (2012-2017)

5 UNITED STATES INCRETIN-BASED DRUGS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Incretin-Based Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Incretin-Based Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES INCRETIN-BASED DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 AstraZeneca plc
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Incretin-Based Drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 AstraZeneca plc Incretin-Based Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Boehringer Ingelheim GmbH
  6.2.2 Incretin-Based Drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Boehringer Ingelheim GmbH Incretin-Based Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 GlaxoSmithKline Plc
  6.3.2 Incretin-Based Drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 GlaxoSmithKline Plc Incretin-Based Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Johnson & Johnson
  6.4.2 Incretin-Based Drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Johnson & Johnson Incretin-Based Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Merck & Co., Inc.
  6.5.2 Incretin-Based Drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Merck & Co., Inc. Incretin-Based Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Takeda Pharmaceutical Company Ltd
  6.6.2 Incretin-Based Drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Takeda Pharmaceutical Company Ltd Incretin-Based Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Sanofi S.A.
  6.7.2 Incretin-Based Drugs Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Sanofi S.A. Incretin-Based Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Novartis AG
  6.8.2 Incretin-Based Drugs Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Novartis AG Incretin-Based Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Eli Lilly and Company
  6.9.2 Incretin-Based Drugs Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Eli Lilly and Company Incretin-Based Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview

7 INCRETIN-BASED DRUGS MANUFACTURING COST ANALYSIS

7.1 Incretin-Based Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Incretin-Based Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Incretin-Based Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Incretin-Based Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES INCRETIN-BASED DRUGS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Incretin-Based Drugs Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Incretin-Based Drugs Sales Volume Forecast by Type (2017-2022)
11.3 United States Incretin-Based Drugs Sales Volume Forecast by Application (2017-2022)
11.4 United States Incretin-Based Drugs Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of Incretin-Based Drugs
Figure United States Incretin-Based Drugs Market Size (MT) by Type (2012-2022)
Figure United States Incretin-Based Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Injectable Product Picture
Figure Oral Product Picture
Figure United States Incretin-Based Drugs Market Size (MT) by Application (2012-2022)
Figure United States Sales Market Share of Incretin-Based Drugs by Application in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Pharmacies Examples
Table Key Downstream Customer in Pharmacies
Figure Diagnostic Centers Examples
Table Key Downstream Customer in Diagnostic Centers
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Incretin-Based Drugs Market Size (Million USD) by Region (2012-2022)
Figure The West Incretin-Based Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Incretin-Based Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Incretin-Based Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Incretin-Based Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Incretin-Based Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Incretin-Based Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Incretin-Based Drugs Sales (MT) and Growth Rate (2012-2022)
Figure United States Incretin-Based Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Incretin-Based Drugs Market Major Players Product Sales Volume (MT) (2012-2017)
Table United States Incretin-Based Drugs Sales (MT) of Key Players/Suppliers (2012-2017)
Table United States Incretin-Based Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Incretin-Based Drugs Sales Share by Players/Suppliers
Figure 2017 United States Incretin-Based Drugs Sales Share by Players/Suppliers
Figure United States Incretin-Based Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Incretin-Based Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Incretin-Based Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Incretin-Based Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Incretin-Based Drugs Revenue Share by Players/Suppliers
Table United States Market Incretin-Based Drugs Average Price (K USD/Kg) of Key Players/Suppliers (2012-2017)
Figure United States Market Incretin-Based Drugs Average Price (K USD/Kg) of Key Players/Suppliers in 2016
Figure United States Incretin-Based Drugs Market Share of Top 3 Players/Suppliers
Figure United States Incretin-Based Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Incretin-Based Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Incretin-Based Drugs Product Category
Table United States Incretin-Based Drugs Sales (MT) by Region (2012-2017)
Table United States Incretin-Based Drugs Sales Share by Region (2012-2017)
Figure United States Incretin-Based Drugs Sales Share by Region (2012-2017)
Figure United States Incretin-Based Drugs Sales Market Share by Region in 2016
Table United States Incretin-Based Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Incretin-Based Drugs Revenue Share by Region (2012-2017)
Figure United States Incretin-Based Drugs Revenue Market Share by Region (2012-2017)
Figure United States Incretin-Based Drugs Revenue Market Share by Region in 2016
Table United States Incretin-Based Drugs Price (K USD/Kg) by Region (2012-2017)
Table United States Incretin-Based Drugs Sales (MT) by Type (2012-2017)
Table United States Incretin-Based Drugs Sales Share by Type (2012-2017)
Figure United States Incretin-Based Drugs Sales Share by Type (2012-2017)
Figure United States Incretin-Based Drugs Sales Market Share by Type in 2016
Table United States Incretin-Based Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Incretin-Based Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Incretin-Based Drugs by Type (2012-2017)
Figure Revenue Market Share of Incretin-Based Drugs by Type in 2016
Table United States Incretin-Based Drugs Price (K USD/Kg) by Types (2012-2017)
Figure United States Incretin-Based Drugs Sales Growth Rate by Type (2012-2017)
Table United States Incretin-Based Drugs Sales (MT) by Application (2012-2017)
Table United States Incretin-Based Drugs Sales Market Share by Application (2012-2017)
Figure United States Incretin-Based Drugs Sales Market Share by Application (2012-2017)
Figure United States Incretin-Based Drugs Sales Market Share by Application in 2016
Table United States Incretin-Based Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Incretin-Based Drugs Sales Growth Rate by Application (2012-2017)
Table AstraZeneca plc Basic Information List
Table AstraZeneca plc Incretin-Based Drugs Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure AstraZeneca plc Incretin-Based Drugs Sales Growth Rate (2012-2017)
Figure AstraZeneca plc Incretin-Based Drugs Sales Market Share in United States (2012-2017)
Figure AstraZeneca plc Incretin-Based Drugs Revenue Market Share in United States (2012-2017)
Table Boehringer Ingelheim GmbH Basic Information List
Table Boehringer Ingelheim GmbH Incretin-Based Drugs Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim GmbH Incretin-Based Drugs Sales Growth Rate (2012-2017)
Figure Boehringer Ingelheim GmbH Incretin-Based Drugs Sales Market Share in United States (2012-2017)
Figure Boehringer Ingelheim GmbH Incretin-Based Drugs Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline Plc Basic Information List
Table GlaxoSmithKline Plc Incretin-Based Drugs Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Plc Incretin-Based Drugs Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Plc Incretin-Based Drugs Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Plc Incretin-Based Drugs Revenue Market Share in United States (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Incretin-Based Drugs Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Johnson & Johnson Incretin-Based Drugs Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Incretin-Based Drugs Sales Market Share in United States (2012-2017)
Figure Johnson & Johnson Incretin-Based Drugs Revenue Market Share in United States (2012-2017)
Table Merck & Co., Inc. Basic Information List
Table Merck & Co., Inc. Incretin-Based Drugs Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Merck & Co., Inc. Incretin-Based Drugs Sales Growth Rate (2012-2017)
Figure Merck & Co., Inc. Incretin-Based Drugs Sales Market Share in United States (2012-2017)
Figure Merck & Co., Inc. Incretin-Based Drugs Revenue Market Share in United States (2012-2017)
Table Takeda Pharmaceutical Company Ltd Basic Information List
Table Takeda Pharmaceutical Company Ltd Incretin-Based Drugs Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Takeda Pharmaceutical Company Ltd Incretin-Based Drugs Sales Growth Rate (2012-2017)
Figure Takeda Pharmaceutical Company Ltd Incretin-Based Drugs Sales Market Share in United States (2012-2017)
Figure Takeda Pharmaceutical Company Ltd Incretin-Based Drugs Revenue Market Share in United States (2012-2017)
Table Sanofi S.A. Basic Information List
Table Sanofi S.A. Incretin-Based Drugs Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Sanofi S.A. Incretin-Based Drugs Sales Growth Rate (2012-2017)
Figure Sanofi S.A. Incretin-Based Drugs Sales Market Share in United States (2012-2017)
Figure Sanofi S.A. Incretin-Based Drugs Revenue Market Share in United States (2012-2017)
Table Novartis AG Basic Information List
Table Novartis AG Incretin-Based Drugs Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Novartis AG Incretin-Based Drugs Sales Growth Rate (2012-2017)
Figure Novartis AG Incretin-Based Drugs Sales Market Share in United States (2012-2017)
Figure Novartis AG Incretin-Based Drugs Revenue Market Share in United States (2012-2017)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Incretin-Based Drugs Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Eli Lilly and Company Incretin-Based Drugs Sales Growth Rate (2012-2017)
Figure Eli Lilly and Company Incretin-Based Drugs Sales Market Share in United States (2012-2017)
Figure Eli Lilly and Company Incretin-Based Drugs Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Incretin-Based Drugs
Figure Manufacturing Process Analysis of Incretin-Based Drugs
Figure Incretin-Based Drugs Industrial Chain Analysis
Table Raw Materials Sources of Incretin-Based Drugs Major Players/Suppliers in 2016
Table Major Buyers of Incretin-Based Drugs
Table Distributors/Traders List
Figure United States Incretin-Based Drugs Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure United States Incretin-Based Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Incretin-Based Drugs Price (K USD/Kg) Trend Forecast (2017-2022)
Table United States Incretin-Based Drugs Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Incretin-Based Drugs Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Incretin-Based Drugs Sales Volume (MT) Forecast by Type in 2022
Table United States Incretin-Based Drugs Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Incretin-Based Drugs Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Incretin-Based Drugs Sales Volume (MT) Forecast by Application in 2022
Table United States Incretin-Based Drugs Sales Volume (MT) Forecast by Region (2017-2022)
Table United States Incretin-Based Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Incretin-Based Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Incretin-Based Drugs Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories